| Financial Year |
March 31 2022 |
| Monetary Funds |
4,950,645.01 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
51,160,477.23 |
| Advances to Suppliers |
7,159,350.58 |
| Other Receivables |
2,198,889.46 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
35,173,967.34 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
17,938,792.85 |
| Total Current Assets |
118,582,122.47 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
860,345,165.54 |
| Under-construction Projects |
404,298,729.71 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
92,502,896.27 |
| R&D expenses |
1,338,642.04 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,149,674.13 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
125,148,256.24 |
| Sub-Total of Non-Current Assets |
1,487,783,363.93 |
| Total Assets |
1,606,365,486.40 |
| Short-Term Loans |
166,550,625.15 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
31,547,404.51 |
| Accounts Received In Advance |
27,525,261.82 |
| Employee Compensation Payable |
9,220,477.95 |
| Taxes Payable |
5,575,170.13 |
| Interest Payable |
38,000,527.72 |
| Dividend Payable |
101,505.15 |
| Other payables |
299,519,713.06 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
177,637,986.94 |
| Other Current Liabilities |
3,685.41 |
| Sub-Total of Current Liabilities |
719,123,079.79 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,808,155.50 |
| Total Liabilities |
723,931,235.29 |
| Paid-In Capital(Or Share Stock) |
547,920,000.00 |
| Capital Surplus |
955,000,926.96 |
| Surplus Reserve |
43,262,706.69 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-654,857,311.99 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
882,434,251.11 |
| Owner's Equity（Stockholder's Equity） |
882,434,251.11 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,606,365,486.40 |
